Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BHAC
Upturn stock ratingUpturn stock rating

Barington/Hilco Acquisition (BHAC)

Upturn stock ratingUpturn stock rating
$10.31
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

12/11/2024: BHAC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 1.6%
Avg. Invested days 68
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/11/2024

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 71.81M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 560
Beta -
52 Weeks Range 10.00 - 12.80
Updated Date 12/12/2024
52 Weeks Range 10.00 - 12.80
Updated Date 12/12/2024
Dividends yield (FY) -
Basic EPS (TTM) -0.25

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -8.18%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 72363757
Price to Sales(TTM) -
Enterprise Value 72363757
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -58.13
Shares Outstanding 5312120
Shares Floating 361298
Shares Outstanding 5312120
Shares Floating 361298
Percent Insiders 71.52
Percent Institutions 20.58

AI Summary

Barington/Hilco Acquisition: A Comprehensive Overview

Company Profile:

Detailed history and background of Barington/Hilco Acquisition:

Barington/Hilco Acquisition Corp. is a publicly traded special purpose acquisition company (SPAC) formed in 2022 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is led by James A. Mitarotonda, Chairman and Chief Executive Officer, and Jason H. Aintabi, President and Chief Operating Officer.

Description of the company’s core business areas:

Barington/Hilco Acquisition does not currently have any operating business. Its sole focus is identifying and completing a qualifying acquisition transaction. The company intends to focus on businesses in the consumer, industrial, and healthcare sectors.

Overview of the company’s leadership team and corporate structure:

  • James A. Mitarotonda: Chairman and Chief Executive Officer. Extensive experience in private equity and investment banking.
  • Jason H. Aintabi: President and Chief Operating Officer. Experience in corporate finance and mergers and acquisitions.
  • Board of Directors: Comprised of experienced professionals with expertise in finance, operations, and M&A.

Top Products and Market Share:

As a SPAC, Barington/Hilco Acquisition does not currently have any products or market share. It will acquire a target company and its products following a successful business combination.

Total Addressable Market:

The total addressable market for Barington/Hilco Acquisition is dependent on the target company it acquires. The company has not yet announced a specific target, but it intends to focus on businesses in the consumer, industrial, and healthcare sectors.

Financial Performance:

As a SPAC, Barington/Hilco Acquisition has limited financial history. Its financial statements primarily reflect the costs associated with being a public company.

Dividends and Shareholder Returns:

Barington/Hilco Acquisition has not yet paid any dividends and does not anticipate doing so until after a business combination.

Growth Trajectory:

The future growth prospects of Barington/Hilco Acquisition are dependent on the target company it acquires. The company has not yet announced a specific target, making it difficult to project future growth.

Market Dynamics:

The SPAC market is currently experiencing a period of decline after a boom in 2020 and 2021. The number of SPAC IPOs and mergers has decreased significantly in 2023.

Competitors:

Barington/Hilco Acquisition competes with other SPACs in the market. Some of its competitors include:

  • Pershing Square Tontine Holdings Ltd. (PSTH)
  • Gores Group Inc. (GOMG)
  • Chamath Palihapitiya's Social Capital Hedosophia (IPOA, IPOB, IPOC)

Potential Challenges and Opportunities:

Key Challenges:

  • Identifying and acquiring a suitable target company.
  • Integrating the acquired company successfully.
  • Achieving the expected financial performance following the acquisition.

Potential Opportunities:

  • Identifying and acquiring a high-growth company with significant potential.
  • Leveraging the experience and expertise of the management team to unlock value.
  • Capitalizing on the current market conditions to acquire a company at an attractive valuation.

Recent Acquisitions (last 3 years):

N/A

AI-Based Fundamental Rating:

While AI-based fundamental analysis can provide insights, it is important to note that it should not be the sole basis for investment decisions. Several factors, including market sentiment, macroeconomic conditions, and company-specific risks, should be considered.

Sources and Disclaimers:

  • Barington/Hilco Acquisition Investor Presentation
  • SEC Filings
  • Bloomberg
  • Reuters

Disclaimer:

This information is for educational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.

About Barington/Hilco Acquisition

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2021-11-30
CEO & Director Mr. Carl M. Stanton CPA
Sector Financial Services
Industry Shell Companies
Full time employees -
Full time employees -

Focus Impact BH3 Acquisition Company does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Crixus BH3 Acquisition Company and changed its name to Focus Impact BH3 Acquisition Company in November 2023. Focus Impact BH3 Acquisition Company was incorporated in 2021 and is based in New York, New York.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​